- Home
- PRLD vs FSEA Comparison
PRLD vs FSEA Comparison
Compare PRLD & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- FSEA
- Stock Information
- Founded
- PRLD 2016
- FSEA 1890
- Country
- PRLD United States
- FSEA United States
- Employees
- PRLD N/A
- FSEA N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- FSEA Savings Institutions
- Sector
- PRLD Health Care
- FSEA Finance
- Exchange
- PRLD Nasdaq
- FSEA Nasdaq
- Market Cap
- PRLD 48.6M
- FSEA 52.8M
- IPO Year
- PRLD 2020
- FSEA N/A
- Fundamental
- Price
- PRLD $0.78
- FSEA $11.25
- Analyst Decision
- PRLD Strong Buy
- FSEA
- Analyst Count
- PRLD 2
- FSEA 0
- Target Price
- PRLD $4.50
- FSEA N/A
- AVG Volume (30 Days)
- PRLD 221.0K
- FSEA 4.1K
- Earning Date
- PRLD 08-11-2025
- FSEA 08-08-2025
- Dividend Yield
- PRLD N/A
- FSEA N/A
- EPS Growth
- PRLD N/A
- FSEA N/A
- EPS
- PRLD N/A
- FSEA 0.00
- Revenue
- PRLD $7,000,000.00
- FSEA $16,196,000.00
- Revenue This Year
- PRLD N/A
- FSEA N/A
- Revenue Next Year
- PRLD N/A
- FSEA N/A
- P/E Ratio
- PRLD N/A
- FSEA $1,369.20
- Revenue Growth
- PRLD N/A
- FSEA 97.61
- 52 Week Low
- PRLD $0.61
- FSEA $8.60
- 52 Week High
- PRLD $6.80
- FSEA $11.80
- Technical
- Relative Strength Index (RSI)
- PRLD 42.16
- FSEA 50.62
- Support Level
- PRLD $0.77
- FSEA $11.17
- Resistance Level
- PRLD $0.84
- FSEA $11.40
- Average True Range (ATR)
- PRLD 0.07
- FSEA 0.11
- MACD
- PRLD -0.02
- FSEA -0.00
- Stochastic Oscillator
- PRLD 16.04
- FSEA 62.50
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.